Skip to main content
Equibles
ACRS $5.32 -3.36%
ACRS logo
ACRS · Aclaris Therapeutics, Inc.
Track ACRS — free

Use ACRS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACRS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.32 -0.19 (-3.36%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$783.10M
Shares
147.20M
All earnings calls

Earnings call · FY2025 Q4

Aclaris Therapeutics, Inc. (ACRS) Q4 2025 Earnings Call

NoCallHeld Jan 6, 2026
Jan 6, 2026 0 turns
Period
FY2025 Q4
Runtime
—
Sources
3 artifacts
8-K 8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $1.29M -85.9% YoY
Net income · derived Q4 -$19.80M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 26, 2026 8-K call announcement Filed Jan 6, 2026 10-K report Filed Feb 26, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

ACRS transcript alerts

Aclaris Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →